Optimal design and patient selection for interventional trials using radiogenomic biomarkers: a REQUITE and Radiogenomics consortium statement.
AuthorsDe Ruysscher, D
Van Staa, T
West, Catharine M L
AffiliationMaastricht University Medical Center, Department of Radiation Oncology (MAASTRO Clinic), The Netherlands
MetadataShow full item record
AbstractThe optimal design and patient selection for interventional trials in radiogenomics seem trivial at first sight. However, radiogenomics do not give binary information like in e.g. targetable mutation biomarkers. Here, the risk to develop severe side effects is continuous, with increasing incidences of side effects with higher doses and/or volumes. In addition, a multi-SNP assay will produce a predicted probability of developing side effects and will require one or more cut-off thresholds for classifying risk into discrete categories. A classical biomarker trial design is therefore not optimal, whereas a risk factor stratification approach is more appropriate. Patient selection is crucial and this should be based on the dose-response relations for a specific endpoint. Alternatives to standard treatment should be available and this should take into account the preferences of patients. This will be discussed in detail.
CitationOptimal design and patient selection for interventional trials using radiogenomic biomarkers: a REQUITE and Radiogenomics consortium statement. 2016, 121(3):440-446 Radiother Oncol
JournalRadiotherapy and Oncology
- Radiogenomics: Identification of Genomic Predictors for Radiation Toxicity.
- Authors: Rosenstein BS
- Issue date: 2017 Oct
- Radiogenomics and IR.
- Authors: Lam A, Bui K, Hernandez Rangel E, Nguyentat M, Fernando D, Nelson K, Abi-Jaoudeh N
- Issue date: 2018 May
- Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy.
- Authors: Kerns SL, Ostrer H, Rosenstein BS
- Issue date: 2014 Feb
- Radiogenomics - current status, challenges and future directions.
- Authors: Andreassen CN, Schack LM, Laursen LV, Alsner J
- Issue date: 2016 Nov 1
- Radiogenomics: radiobiology enters the era of big data and team science.
- Authors: Rosenstein BS, West CM, Bentzen SM, Alsner J, Andreassen CN, Azria D, Barnett GC, Baumann M, Burnet N, Chang-Claude J, Chuang EY, Coles CE, Dekker A, De Ruyck K, De Ruysscher D, Drumea K, Dunning AM, Easton D, Eeles R, Fachal L, Gutiérrez-Enríquez S, Haustermans K, Henríquez-Hernández LA, Imai T, Jones GD, Kerns SL, Liao Z, Onel K, Ostrer H, Parliament M, Pharoah PD, Rebbeck TR, Talbot CJ, Thierens H, Vega A, Witte JS, Wong P, Zenhausern F, Radiogenomics Consortium.
- Issue date: 2014 Jul 15